Enwave Corporation Stock
?
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -2.480% | -1.026% | -13.839% | 16.265% | -18.220% | -10.648% | -80.929% |
| Aurinia Pharmaceuticals Inc. | 1.210% | -1.146% | -2.186% | 59.915% | -10.319% | 57.826% | -8.276% |
| Spectral Medical Inc | 6.370% | 0.641% | -5.422% | 86.905% | -1.258% | 266.822% | 76.009% |
| Xenon Pharmaceuticals Inc. | 1.140% | 0.571% | -1.676% | -6.383% | -7.368% | -1.676% | - |
News
EnWave Signs Royalty-Bearing License with Bowen Gumlu Grower’s Association of Australia
Vancouver, B.C., February 2nd, 2026, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a royalty-bearing commercial license
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement

